Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements

Thrombosis Research

Volumn 117, Issue 1-2, 2005, Pages 55-59

  Gage, Brian F ^a   Milligan, Paul E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN; COLESTYRAMINE; COUMARIN; CYTOCHROME P450 2C9; GARLIC EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLUCOSAMINE; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; PHENPROCOUMON; SABAL EXTRACT; UBIDECARENONE; VITAMIN K GROUP; WARFARIN;

ANTICOAGULATION; AREA UNDER THE CURVE; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENCY; ENZYME INDUCTION; ENZYME INHIBITION; GENOTYPE; GINSENG; HEART FAILURE; HEPATOBILIARY DISEASE; HUMAN; HYPERICUM PERFORATUM; LOW DRUG DOSE; MYOPATHY; NONHUMAN; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOYBEAN; SUPPLEMENTATION; TEA; THROMBOCYTE AGGREGATION; THROMBOSIS;

COUMARINS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD-DRUG INTERACTIONS; HUMANS; PHARMACOGENETICS; WARFARIN;

EID: 27744495649     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.06.009     Document Type: Conference Paper

References (22)

1. B.F. Gage, S.D. Fihn, and R.H. White Management and dosing of warfarin therapy Am J Med 109 6 2000 481 488
2. R.L. Rich, Y.S. Day, T.A. Morton, and D.G. Myszka High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE Anal Biochem 296 2 2001 197 207
3. Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, et al. Validation of clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation [in press]. Am Heart J 2005.
4. L. Harrison, M. Johnston, M.P. Massicotte, M. Crowther, K. Moffat, and Hirsh Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy Ann Intern Med 126 1997 133 136
5. B.F. Gage, C. Eby, P.E. Milligan, G.A. Banet, J.R. Duncan, and H.L. McLeod Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin Thromb Haemost 91 1 2004 87 94
6. M.K. Higashi, D.L. Veenstra, L.M. Kondo, A.K. Wittkowsky, S.L. Srinouanprachanh, and F.M. Farin Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy JAMA 287 13 2002 1690 1698
7. M. Margaglione, D. Colaizzo, G. D'Andrea, V. Brancaccio, A. Ciampa, and E. Grandone Genetic modulation of oral anticoagulation with warfarin Thromb Haemost 84 5 2000 775 778
8. D. Voora, C. Eby, M.W. Linder, P.E. Milligan, B.L. Bukaveckas, and H.L. McLeod Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype Thromb Haemost 93 4 2005 700 705
9. D. Voora, H.L. McLeod, C. Eby, and B.F. Gage Use of pharmacogenetics to guide warfarin therapy Drugs Today (Barc) 40 3 2004 247 257
10. M.J. Rieder, A.P. Reiner, B.F. Gage, D.A. Nickerson, C.S. Eby, and H.L. McLeod Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose N Engl J Med 352 2005 2285 2293
11. G. D'Andrea, R.L. D'Ambrosio, P. Di Perna, M. Chetta, R. Santacroce, and V. Brancaccio A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin Blood 105 2 2005 645 649
12. I.H. Zuckerman, E.K. Steinberger, P.T. Ryder, and S. Haines Herbal product use among anticoagulation clinic patients Am J Health Syst Pharm 59 4 2002 379 380
13. L. Smith, E. Ernst, PaulEwings, P. Myers, and C. Smith Co-ingestion of herbal medicines and warfarin Br J Gen Pract 54 503 2004 439 441
14. R.S. Wong, G. Cheng, and T.Y. Chan Use of herbal medicines by patients receiving warfarin Drug Safety 26 8 2003 585 588
15. A.M. Holbrook, J.A. Pereira, R. Labiris, H. McDonald, J.D. Douketis, and M. Crowther Systematic overview of warfarin and its drug and food interactions Arch Intern Med 165 10 2005 1095 1106
16. C.S. Yuan, G. Wei, L. Dey, T. Karrison, L. Nahlik, and S. Maleckar Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial Ann Intern Med 141 1 2004 23 27
17. X. Jiang, K.M. Williams, W.S. Liauw, A.J. Ammit, B.D. Roufogalis, and C.C. Duke Effect of St. John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects Br J Clin Pharmacol 57 5 2004 592 599
18. A.J.A. Maurer, and S. Bauer Interaction of St. John's wort extract with phenprocoumon [abstract] Eur J Clin Pharmacol 1999 55 1999 A22
19. A.A. Izzo, G. Di Carlo, F. Borrelli, and E. Ernst Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction Int J Cardiol 98 1 2005 1 14
20. J. Engelsen, J.D. Nielsen, and K. Winther Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial Thromb Haemost 87 6 2002 1075 1076
21. Q. Zhou, S. Zhou, and E. Chan Effect of coenzyme Q10 on warfarin hydroxylation in rat and human liver microsomes Curr Drug Metab 6 2 2005 67 81
22. B.F. Gage, and C.S. Eby The genetics of vitamin K antagonists Pharmacogenomics J 4 2004 224 225